| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.06 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |